Jay W. Schmelter is a co-founder and Managing Director of RiverVest Venture Partners, a St. See sector focus and contact routes.
Jay W. Schmelter is a co-founder and Managing Director of RiverVest Venture Partners, a St. Louis-based life science venture firm he established in 2000 to proactively build medical technology companies rather than passively provide capital. His investment thesis focuses exclusively on the life sciences sector, with a distinctive emphasis on the medical device industry, targeting companies that address unmet medical needs through novel biopharmaceuticals and technologies. RiverVest typically engages in early-stage development, often leading investments to guide CEOs from product development through to market entry, leveraging Schmelter’s prior experience founding Salient Surgical Technologies. While specific check sizes are not publicly detailed for individual deals, the firm’s tracked portfolio includes significant transactions such as a $70.0 million Series A investment in Excellergy, indicating a capacity for substantial capital deployment. Notable portfolio companies include Salient Surgical Technologies, which Schmelter founded before RiverVest, as well as CyDex Pharmaceuticals and Excellergy, all serving patients by bringing innovative healthcare solution
Details on this investor come from filing and round data held in the StartupFundraising directory, refreshed on ingest. Founders use profiles like this one to qualify fit and to shortlist investors in St Louis.
Investors like Jay W. Schmelter · Full investor directory · Investor access · Company funding database